•   Name: Dr. Naresh Somani
  •   Department: Medical Oncology
  •   Designation: Senior Consultant & HOD Clinical Trials & Research Deptt.

Make an Appointment


  • MD (SMS Medical College, Jaipur) 1996
  • DM (Cancer Institute, Chennai) 1999
  • Training from Royal Adelaide Hospital,Adelaide,Australia


  • With 18 years of Medical Oncology and trained at Royal Adelaide Hospital – Australia
  • Published articles in JCO, European Journal, LANCET, South Asian Journal and more than 20 publications.


  • Organized: BMCON-II, 16th ICON 2007, ICCN Conference, Scientific Secretary-JMA & MPS
  • Conducted 45 Phase 1 To 3 National/ International clinical trials as Principal Investigator including molecules like Axitinib, Aflibercept, Afatinib, Lanriotide, Caspofungin, Pemetrexed, Sunitinib and Earlotinib, Ceritinib, CLDK, CBKM, Crizotinib, Ribociclib, Pazopanib, Nivolumab, Dinutuximab, Buparsilib Etc.
  • Index Journal Publications :20
  • Published a book :CANCER UPCHAAR ( in Hindi) for patients
  • Awarded by Rajasthan Medical Council for extra ordinary performance in Medical Oncology for meritorious and dedicated services in humanitarian approach (2017).
  • “Best Oncologist of Jaipur” award based on Patient Feedback survey by Innate Group of Company (Sep 2014)
  • “ICON of Rajasthan” award by India Today Group (Aug 2014)
  • Young JMA Achievement Award-2010
  • Young MPS Achievement Award 2008-09

Advisory & Faculty

  • Presented to DCGI as Lead Investigator for United Therapeutics (USA) for SCLC Clinical Trial in India.
  • Member, Medical Advisory Board of Provectus Biopharmaceuticals, INC, USA for development of PV-10 molecule for Phase-1 & Phase-2 Clinical Trial in India.

Email I.D

  • dr.nareshsomani@bmchrc.com

Landline No

  • 0141-5107777, EXT – 133
Posted in